NCT07170020View on ClinicalTrials.gov

Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections

NANot yet recruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

November 14, 2025

Primary Completion Date

November 14, 2026

Study Completion Date

November 14, 2027

Conditions

Necrotizing Fascitis

Interventions

PROCEDURE

Hyperbaric Oxygen Therapy

Hyperbaric oxygen has been shown in several case studies and retrospective studies to possibly improve mortality and morbidity in this patient population. One limitation of prior studies is many of them are retrospective. This study will be prospective.

Trial Locations (1)

49503

Corewell Health, Grand Rapids

All Listed Sponsors

lead

Spectrum Health Hospitals

OTHER

NCT07170020 - Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections | Biotech Hunter | Biotech Hunter